drugset / Trial / NCT00205777

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

NCT00205777

Phase 3 Completed 7609 enrolled Pfizer
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.

Timeline

Start
2001-12
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bazedoxifene Other / unclassified 20 mg Oral

Indications